Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1123760.RAo7bo3-6nD5YHsYjPV3xETxMgf0uyB_6RjYT5SEj7SQo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1123760.RAo7bo3-6nD5YHsYjPV3xETxMgf0uyB_6RjYT5SEj7SQo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1123760.RAo7bo3-6nD5YHsYjPV3xETxMgf0uyB_6RjYT5SEj7SQo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1123760.RAo7bo3-6nD5YHsYjPV3xETxMgf0uyB_6RjYT5SEj7SQo130_provenance.
- NP1123760.RAo7bo3-6nD5YHsYjPV3xETxMgf0uyB_6RjYT5SEj7SQo130_assertion description "[These data demonstrate that PKC? is required for a TIC phenotype in ovarian cancer, and that auranofin is an attractive therapeutic option to target deadly ovarian TICs in ovarian cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1123760.RAo7bo3-6nD5YHsYjPV3xETxMgf0uyB_6RjYT5SEj7SQo130_provenance.
- NP1123760.RAo7bo3-6nD5YHsYjPV3xETxMgf0uyB_6RjYT5SEj7SQo130_assertion evidence source_evidence_literature NP1123760.RAo7bo3-6nD5YHsYjPV3xETxMgf0uyB_6RjYT5SEj7SQo130_provenance.
- NP1123760.RAo7bo3-6nD5YHsYjPV3xETxMgf0uyB_6RjYT5SEj7SQo130_assertion SIO_000772 24174471 NP1123760.RAo7bo3-6nD5YHsYjPV3xETxMgf0uyB_6RjYT5SEj7SQo130_provenance.
- NP1123760.RAo7bo3-6nD5YHsYjPV3xETxMgf0uyB_6RjYT5SEj7SQo130_assertion wasDerivedFrom befree-2016 NP1123760.RAo7bo3-6nD5YHsYjPV3xETxMgf0uyB_6RjYT5SEj7SQo130_provenance.
- NP1123760.RAo7bo3-6nD5YHsYjPV3xETxMgf0uyB_6RjYT5SEj7SQo130_assertion wasGeneratedBy ECO_0000203 NP1123760.RAo7bo3-6nD5YHsYjPV3xETxMgf0uyB_6RjYT5SEj7SQo130_provenance.
- befree-2016 importedOn "2016-02-19" NP1123760.RAo7bo3-6nD5YHsYjPV3xETxMgf0uyB_6RjYT5SEj7SQo130_provenance.